Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Emolux OC** is a marketed topical dermatologic skin-care moisturizer from **JACKS** designed for oily, acne-prone, and sensitive skin. It is described as an oil-control moisturizer with **SPF 15** and a multi-ingredient moisturizing/barrier-support formulation that includes **ceramides**, **sodium hyaluronate**, and **lecithin**. Its intended functional activity is maintenance of the skin barrier, hydration and water retention, and reduction of greasy skin feel while providing non-comedogenic moisturization and basic photoprotection. This appears to be a commercial cosmeceutical/dermatology product rather than a clinical-stage molecular therapeutic, and no specific drug-development pipeline, molecular target program, or trial-based mechanism was identified.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Emolux OC.